Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study

Soriano, Enrique R.; Rosa, Javier; Velozo, E.; Schpilberg, Monica; Imamura, Patricia M.; Díaz, Jorge F. Pérez-Oliva; Catoggio, Luís J.

doi:10.1093/rheumatology/keq369

Cited by 71 publications

(32 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…9–12 Only a few reports of the prevalence of PsA in South America and Asia exist and suggest that the prevalence is lower in these regions (0.07% in Buenos Aires and 0.02% in China). 13, 14 The low prevalence of PsA in China may be due to underdiagnosis as suggested in a study by Yang et al 15 Discrepancies in the prevalence of PsA among these studies is often related to differing definitions of PsA (e.g. use of ICD9 or medical codes versus use of clinical classification criteria).…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

The Epidemiology of Psoriatic Arthritis

Ogdie

Weiss

2015

Rheumatic Disease Clinics of North America

396

256

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

“…The reported incidence of PsA in recent publications ranges from 3.6–7.2 per 100,000 person years. 8, 13, 16, 17 However, publications in 2001–2003 reported a much wider incidence range (0.1–23.1). 18 …”

Section: Methodsmentioning

confidence: 99%

The Epidemiology of Psoriatic Arthritis

Ogdie

Weiss

2015

Rheumatic Disease Clinics of North America

396

256

View full text Add to dashboard Cite

“…Physicians at the institutes were asked to review the medical records. The incidence rates reported in several studies from Finland, Sweden, Czechoslovakia, Greece, Argentina and the USA were fairly uniform ranging from 3.0 to 8/100.000 [63, 86-90]. However, data from two Finnish studies were conflicting.…”

Section: Literature Review On Prevalence and Incidence Spamentioning

confidence: 99%

“…The majority of studies were performed in Europe and the USA [45, 62, 85, 88, 89, 90, 91]. Cross-sectional population surveys that collect data directly from subjects reported a higher prevalence than retrospective studies which were based on medical record review.…”

Section: Literature Review On Prevalence and Incidence Spamentioning

confidence: 99%

Epidemiology of Spondyloarthritis

Stolwijk

Boonen

Tubergen

et al. 2012

Rheumatic Disease Clinics of North America

197

125

View full text Add to dashboard Cite

Synopsis Spondyloarthritis (SpA) represents a group of interrelated diseases with common clinical features and a close association with HLA-B27. Figures on the incidence and prevalence of diseases vary highly dependent on methodological differences between studies, the case definition used to classify disease and on the prevalence of HLA-B27 in the population studied. When summarizing the available literature, incidence rates of SpA are mainly based on the ESSG criteria and range between 0.48 and 63/100.000 while prevalence rates vary between 0.01 and 2.5%. For ankylosing spondylitis (AS), the most widely recognized representative of the SpA group of diseases, incidence rates of 0.44-7.3/100.000 and prevalence rates of 0.007-1.7% have been described in studies that were based on the (modified) New York criteria to classify cases. The incidence of psoriatic arthritis (PsA) varied from 3.6 up to 23.1/100.000 in different studies and prevalence between <0.1% and 0.4%, using a variety of classification criteria. The incidence of ReA has been estimated between 0.6 up to 28/100.000 in studies based on different source populations and different case definitions. The newly proposed criteria for axial SpA and peripheral SpA present an attractive new approach to facilitate classification of the SpA into two main subtypes and the axial SpA criteria allow earlier detection of patents with inflammatory back pain. It should be emphasized that these criteria were developed for use in a (specialized) clinical setting and not for large epidemiological studies.

show abstract

“…In Argentina, the estimated incidence is 6.26 (95% CI 4.2–8.3) cases per 100,000 person-years and the prevalence is 74/100,000 inhabitants [1]. Patients with psoriasis can develop psoriatic arthritis (PsA) in 7–26% of cases, and this situation results in worse morbidity, less functional capacity, poor quality of life, and higher mortality [2–6].…”

Section: Introductionmentioning

confidence: 99%

Spanish Validation of the GEPARD Questionnaire for the Detection of Psoriatic Arthritis in Argentinian Patients with Psoriasis

Martire

Bosch

Scarafia³

et al. 2019

Dermatology

View full text Add to dashboard Cite

Background/Objective: Psoriatic arthritis (PsA) is preceded by psoriasis in approximately 80% of cases. Dermatologists are pivotal for early detection. It is important to have simple tools that allow the detection of PsA in patients with skin psoriasis. The aim of our study was to evaluate the performance of an adapted version of the GEPARD Questionnaire in Spanish in Argentinian patients with psoriasis. Methods: This is a cross-sectional study. A new Spanish (Argentinian) (GEPARDa) translated version of the original questionnaire (German) was developed and then tested as a diagnostic tool in patients with psoriasis, PsA, osteoarthritis associated to psoriasis, and osteoarthritis, all evaluated by rheumatologists who used the CASPAR criteria. Results: Eighty-three patients were included (55 [66.3%] women with a mean age of 50.7 years [SD 6.3]). Forty-four patients had PsA (29 [34.9%] patients had previous diagnosis of PsA, and 15 [18%] were newly diagnosed after referral by their dermatologists), and 39 patients were without PsA (18 [21.6%] patients had psoriasis without articular involvement, 6 [7.22%] had psoriasis associated with osteoarthritis, and 15 [18%] had osteoarthritis). An area under the curve of 0.9554 (SD 0.01; 95% CI 0.91–0.99) was calculated considering the CASPAR criteria as the gold standard. With a cutoff of ≥6 the questionnaire showed a sensitivity of 88.64%, a specificity of 89.74%, a positive likelihood ratio of 8.6, and a negative likelihood ratio of 0.12. Conclusions: The GEPARDa version has proven to be a diagnostic tool with excellent performance so that it can be considered a valid tool for the detection of PsA in Argentinian patients.

show abstract

Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study

Abstract: The incidence and prevalence of PsA in this Latin American country was similar to that reported in other studies from Europe and the USA.

Cited by 71 publications

References 16 publications

The Epidemiology of Psoriatic Arthritis

The Epidemiology of Psoriatic Arthritis

Epidemiology of Spondyloarthritis

Spanish Validation of the GEPARD Questionnaire for the Detection of Psoriatic Arthritis in Argentinian Patients with Psoriasis

Contact Info

Product

Resources

About